BUB1 Antibodies

Santa Cruz Biotechnology delivers a wide array of BUB1 monoclonal antibodies for research in cell cycle regulation and mitotic checkpoint control. BUB1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BUB1, or Budding Uninhibited by Benzimidazoles 1, plays a critical role in ensuring proper chromosome segregation during cell division. BUB1 functions as a key component of the spindle assembly checkpoint, preventing anaphase onset until all chromosomes are correctly attached to the spindle apparatus. Dysregulation of BUB1 has been implicated in various cancers, highlighting its importance in maintaining genomic stability. Understanding BUB1's role in cell cycle regulation provides valuable insights into cancer development and progression. Research utilizing BUB1 monoclonal antibodies continues to reveal new aspects of chromosome segregation and cell division mechanisms. Investigating BUB1 functions aids in developing targeted therapeutic strategies for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle dynamics and their implications in disease development.